Cardiovascular Agents
Formulations for the management of hypertension, heart failure, hyperlipidaemia, angina, peripheral vascular disease, and cardiac arrhythmias. Includes antihypertensives (ARBs, ACE inhibitors, beta-blockers), antiplatelets, statins, and aldosterone antagonists.
19
Products (SKUs)
Who-GMP
Certified Facility
FDCA
(Gujarat) Approved
Export
Ready
| SR | PRODUCT NAME | DOSAGE FORM | PHARMACOLOGICAL SUB-CLASS |
|---|---|---|---|
| 1 | Rosuvastatin Calcium Tablets IP 5 mg | Tablet (IP) | Statin (HMG-CoA Reductase Inhibitor) |
| 2 | Rosuvastatin Calcium Tablets IP 10 mg | Tablet (IP) | Statin |
| 3 | Rosuvastatin Calcium Tablets IP 20 mg | Tablet (IP) | Statin |
| 4 | Rosuvastatin Calcium Tablets IP 40 mg | Tablet (IP) | Statin |
| 5 | Rosuvastatin Tablets BP 10 mg | Tablet (BP) | Statin |
| 6 | Rosuvastatin Tablets USP 10 mg | Tablet (USP) | Statin |
| 7 | Rosuvastatin Tablets USP 20 mg | Tablet (USP) | Statin |
| 8 | Atorvastatin Calcium Tablets 10 mg | Tablet | Statin |
| 9 | Atorvastatin Tablets BP 10 mg | Tablet (BP) | Statin |
| 10 | Losartan Potassium Tablets IP 25 mg | Tablet (IP) | ARB Antihypertensive |
| 11 | Losartan Potassium Tablets IP 50 mg | Tablet (IP) | ARB Antihypertensive |
| 12 | Losartan Potassium & Hydrochlorothiazide Tablets IP | Tablet (IP) | ARB + Diuretic Combination |
| 13 | Losartan Potassium & Hydrochlorothiazide Tablets USP | Tablet (USP) | ARB + Diuretic Combination |
| 14 | Candesartan Cilexetil Tablets USP 16 mg | Tablet (USP) | ARB Antihypertensive |
| 15 | Bisoprolol Tablets USP 5 mg | Tablet (USP) | Beta-Blocker |
| 16 | Bisoprolol Fumarate Tablets USP 5 mg | Tablet (USP) | Beta-Blocker |
| 17 | Captopril Tablets BP 25 mg | Tablet (BP) | ACE Inhibitor |
| 18 | Sacubitril & Valsartan 50 mg Tablets | Tablet | Neprilysin Inhibitor + ARB (HFrEF) |
| 19 | Ticagrelor Tablets BP 90 mg | Tablet (BP) | Antiplatelet (P2Y12 Inhibitor) |
PARTNER FOR BETTER HEALTH OUTCOMES
Let’s build healthier tomorrows together.
We are open to partnerships, tenders, and global collaborations.
Get in touch with our team to explore opportunities.
